ISSN 1662-4009 (online)

ey0017.6-21 | Transgender Medicine: Fertility | ESPEYB17

6.21. Attitudes toward fertility preservation among transgender youth and their parents

RW Persky , SM Gruschow , N Sinaii , C Carlson , JP Ginsberg , NL Dowshen

To read the full abstract: J Adolesc Health. 2020, Apr 29; 10.1016/j.jadohealth.2020.02.027. doi: 10.1016/j.jadohealth.2020.02.027, PMID 32359942. https://www.ncbi.nlm.nih.gov/pubmed/32359942Fertility preservation among transgender youth undergoing gender-affirming hormone treatment is a topic of increasing interest. This ...

ey0016.9-4 | Metabolic and Cardiovascular Risk in Cancer Survivors | ESPEYB16

9.4. Diabetes risk in childhood cancer survivors: A population-based study

IC Lega , JD Pole , PC Austin , C Lau , PC Nathan , NN Baxter

To read the full abstract: Can J Diabetes. 2018 Oct; 42(5): 533.This retrospective population-based study focused on diabetes prevalence in childhood cancer survivors (CCSs) using administrative health care databases of the Canadian National Health System. The authors compared 10,438 CCSs (mean age 10.7±6.8 years; mean follow-up time 11.2±6.9 years) with 52,190 age- and sex-mat...

ey0016.15-7 | (1) | ESPEYB16

15.7. Association of early introduction of solids with infant sleep: A secondary analysis of a randomized clinical trial

MR Perkin , HT Bahnson , K Logan , T Marrs , S Radulovic , J Craven , C Flohr , G Lack

To read the full abstract: JAMA Pediatr 2018;172:e180739.This randomised controlled trial of 1303 exclusively breastfed 3-month-old UK infants was primarily performed to test the impact of early introduction of solid foods, from age 3 months, on the risk of food allergies (1). Sleep was measured as a secondary trial outcome: the trial showed that early introduction of solids increa...

ey0017.8-13 | New Concerns | ESPEYB17

8.13. Adverse childhood experiences, DNA methylation age acceleration, and cortisol in UK children: a prospective population-based cohort study

Tang Rosalind , Howe Laura D , Suderman Matthew , Relton Caroline L , Crawford Andrew A , Houtepen Lotte C

To read the full abstract: Clin Epigenetics. 2020; 12: 55. PMID: 32264940.A large body of evidence has documented the long-term consequences of adverse childhood experiences (ACEs) on social and health outcomes in later life (1). However, the underlying mechanisms remain unclear. Epigenetic mechanisms may explain the lasting effects of early life adversity (2</stron...

ey0016.4-12 | New Paradigms | ESPEYB16

4.12. Expression of insulin-like growth factor I and its receptor in the liver of children with biopsy-proven NAFLD

A Alisi , V Pampanini , C De Stefanis , N Panera , A Deodati , V Nobili , S Cianfarani

To read the full abstract: PLoS One. 2018;13:e0201566.NAFLD is a multifactorial disease characterized by an abnormal accumulation of fat in the liver without a history of significant alcohol intake. NAFLD is the most common form of chronic liver disease, affecting 30% of adults and 10% of children in the USA [1]. Alarmingly, its prevalence is increasing worldwide paralleling to the incre...

ey0015.7-13 | Secular trends and Turner syndrome | ESPEYB15

7.13 Secular Trends on Birth Parameters, Growth, and Pubertal Timing in Girls with Turner Syndrome

J Woelfle , A Lindberg , F Aydin , KK Ong , C Camacho-Hubner , B Gohlke

To read the full abstract: Front Endocrinol (Lausanne). 2018 Feb 28;9:54Secular trends in birth parameters1-3, growth4,5, and timing of puberty6-8 are observed in normal populations. Changes in nutrition, better access to health care, and other environmental factors have been implicated as causative factors for those changes. Here, the authors assessed secular ...

ey0021.11-4 | Interventions for Weight Loss: New Findings | ESPEYB21

11.4. Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial

CL Roth , C Scimia , AH Shoemaker , M Gottschalk , J Miller , G Yuan , S Malhotra , MJ Abuzzahab

Brief Summary: This phase 2, open-label, multicenter trial examined the efficacy of setmelanotide, a melanocortin-4 receptor agonist, in patients aged 6 to 40 years with obesity due to hypothalamic injury. Setmelanotide reduced body mass index (BMI) and hunger levels in most participants; 89% achieved a reduction in BMI of at least 5% after 16 weeks. These results indicate that setmelanotide is a promising treatment for hypothalamic obesity.This phase 2 ...

ey0020.8-1 | Clinical Trials – New Treatments | ESPEYB20

8.1. Effect of Verapamil on pancreatic beta cell function in newly diagnosed pediatric type 1 diabetes: A randomized clinical trial

GP Forlenza , J McVean , RW Beck , C Bauza , R Bailey , B Buckingham , LA DiMeglio , JL Sherr , M Clements , A Neyman , C Evans-Molina , EK Sims , LH Messer , L Ekhlaspour , R McDonough , M Van Name , D Rojas , S Beasley , S DuBose , C Kollman , A Moran , CLVer Study Group

Brief summary: In this double-blind, randomized clinical trial conducted in 6 US centres, 88 children and adolescents (aged 7–17 years) with newly diagnosed type 1 diabetes (T1D) were randomized to either once-daily oral verapamil or placebo, within 1 month from diagnosis. Treatment with verapamil led to better stimulated C-peptide secretion at 52 weeks post-diagnosis, with levels 30% higher compared to placebo.Verapamil is a calcium channel blocker...

ey0017.8-2 | New Mechanisms | ESPEYB17

8.2. Cognitive dysfunction in mice lacking proper glucocorticoid receptor dimerization

K Van Looveren , M Van Boxelaere , Z Callaerts-Vegh , C Libert

To read the full abstract: PLoS One. 2019; 14(12): e0226753. PMID: 31869387.Glucocorticoids (cortisol in humans, corticosterone in most rodents) are steroid hormones secreted by the adrenal cortex into the systemic circulation in an ultradian, circadian, and stress-related fashion under the control of the hypothalamic-pituitary-adrenal (HPA) axis. These cholesterol-derived molecules partici...

ey0021.4-12 | New Mechanisms | ESPEYB21

4.12. Metabolic surgery-induced changes of the growth hormone system relate to improved adipose tissue function

S Gancheva , S Kahl , C Herder , K Strassburger , T Sarabhai , K Pafili , J Szendroedi , M Schlensak , M Roden

Brief Summary: This longitudinal study explored the impact of metabolic surgery on the growth hormone (GH)/IGF-1 axis and its subsequent effects on adipose tissue function. The results suggest that bariatric surgery enhances GH-IGF-1 levels, which are linked to improved adipose tissue function and a reduction in inflammation markers.This study explored how metabolic surgery influences the GH system, and how these changes are related to improvements in ad...